000 | 01993 a2200565 4500 | ||
---|---|---|---|
005 | 20250515193231.0 | ||
264 | 0 | _c20100108 | |
008 | 201001s 0 0 eng d | ||
022 | _a1476-5586 | ||
024 | 7 |
_a10.1593/neo.09878 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBacker, Joseph M | |
245 | 0 | 0 |
_aChaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _cNov 2009 |
||
300 |
_a1165-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Toxins _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
650 | 0 | 4 | _aEndoplasmic Reticulum Chaperone BiP |
650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeat-Shock Proteins _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Folding _xdrug effects |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xpharmacology |
650 | 0 | 4 |
_aStress, Physiological _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aKrivoshein, Arcadius V | |
700 | 1 | _aHamby, Carl V | |
700 | 1 | _aPizzonia, John | |
700 | 1 | _aGilbert, Kenneth S | |
700 | 1 | _aRay, Yonaton S | |
700 | 1 | _aBrand, Harrison | |
700 | 1 | _aPaton, Adrienne W | |
700 | 1 | _aPaton, James C | |
700 | 1 | _aBacker, Marina V | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 11 _gno. 11 _gp. 1165-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.09878 _zAvailable from publisher's website |
999 |
_c19270526 _d19270526 |